title: Single dose pharmacokinetics of piroxicam in cats.
abstract: Piroxicam (PIRO) is a nonsteroidal anti-inflammatory drug (NSAID) recognized for its value as a chemopreventative and anti-tumor agent. Eight cats were included in this study. PIRO was administered in a single oral (p.o.) and intravenous (i.v.) dose of 0.3 mg/kg. The study was designed as a randomized complete crossover with a 2-week washout period. Serial blood samples were collected after each dose and plasma was analyzed for PIRO. Pharmacokinetic parameters of PIRO were determined using noncompartmental analysis. PIRO is well absorbed in the cat with a median bioavailability (F) of 80% (range 64-124%). The median i.v. t1/2 was 12 h (range 8.6-14 h). The median Cmax was 519 ng/mL with a corresponding Tmax of 3 h. PIRO appears to be rapidly absorbed following p.o. administration in cats with a higher Cmax and AUC than in dogs.
authors.affiliation: Department of Clinical Sciences and; Department of Anatomy and Physiology, Kansas State University, College of Veterinary Medicine, Mosier Hall, Manhattan, KS 66506, USA. hheeb@vet.ksu.edu
authors.forename: H L
authors.initials: HL
authors.lastname: Heeb
authors.forename: R
authors.initials: R
authors.lastname: Chun
authors.forename: D E
authors.initials: DE
authors.lastname: Koch
authors.forename: M A
authors.initials: MA
authors.lastname: Goatley
authors.forename: R P
authors.initials: RP
authors.lastname: Hunter
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001682:Biological Availability; D002415:Cats; D018592:Cross-Over Studies; D007262:Infusions, Intravenous; D008297:Male; D010894:Piroxicam / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam